OS Therapies Inc
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
OSTX$0.89-3.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2024 and 2023
Balance Sheets
| December 31, | December 31, | |
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Current Assets | ||
| Cash | $5,533,527 | $38,982 |
| Deferred Offering Costs | - | 751,050 |
| Total Current Assets | 5,533,527 | 790,032 |
| Long Term Assets | ||
| Fixed Assets (Net) | 5,270 | 8,050 |
| TOTAL ASSETS | $5,538,797 | $798,082 |
| LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT | ||
| Current Liabilities | ||
| Accounts Payable | $1,662,068 | $2,715,399 |
| Accrued Interest on Convertible Notes | - | 2,026,323 |
| Accrued Expenses | 521,010 | 162,500 |
| Accrued Payroll and Payroll Taxes – Related Party | 97,257 | 112,137 |
| Accrued Payroll and Payroll Taxes | - | 33,543 |
| Redemption Premium | - | 4,580,304 |
| Preferred Dividends Payable | 375,000 | 343,750 |
| Convertible Notes – A (Net Debt Discount) | - | 1,051,032 |
| Convertible Notes – A (Related Party Net Debt Discount) | - | 100,000 |
| Convertible Notes – B (Net Debt Discount) | - | 5,154,000 |
| Convertible Notes – C (Net Debt Discount) | - | 3,873,417 |
| Convertible Notes – D (Net Debt Discount) | - | 1,950,160 |
| Convertible Notes – E (Net Debt Discount) | - | 1,100,000 |
| Convertible Notes – F (Net Debt Discount) | - | 1,381,732 |
| Warrant Liability (Net of Discount) | 1,971,975 | - |
| Make-whole Stock Liability | - | 130,000 |
| Total Current Liabilities | 4,627,310 | 24,714,297 |
| Long Term Liabilities | ||
| TEDCO Grant | 100,000 | 100,000 |
| Total Long Term Liabilities | 100,000 | 100,000 |
| Total Liabilities | 4,727,310 | 24,814,297 |
| Commitments and contingencies (See Note 9) | ||
| MEZZANINE EQUITY: | ||
| Series A Convertible Preferred Stock, par value $0.001, 2,500,000 shares authorized; 1,512,500 and 0 issued and outstanding, respectively | 6,050,000 | - |
| Total Mezzanine Equity | 6,050,000 | - |
| STOCKHOLDERS’ DEFICIT | ||
| Common Stock A, par value $0.001, 50,000,000 shares authorized; 20,869,908 and 5,340,000 issued and outstanding, respectively | 20,870 | 5,340 |
| Preferred Stock, par value $0.001, 5,000,000 shares authorized; 0 and 0 shares outstanding, respectively | - | 1,302 |
| Additional paid-in capital | 35,144,967 | 5,495,330 |
| Accumulated deficit | (40,404,350) | (29,518,187) |
| Total Stockholders’ Deficit | (5,238,513) | (24,016,215) |
| TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT | $5,538,797 | $798,082 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.